The aim of this review is to provide an overview of the current knowledge on the mechanisms by which PI3K/Akt signaling regulates obesity-induced inflammation in AT and discuss novel pharmacological strategies to resolve or relapse meta-inflammation. The gene discussed is PIK3CD; the disease is Obesity.